|
J Biol Chem, Vol. 273, Issue 13, 7604-7609, March 27, 1998
The Intermediate Filament Protein, Vimentin, in the Lens Is a
Target for Cross-linking by Transglutaminase
Sophie
Clément ,
Pauline T.
Velasco ,
S. N. Prasanna
Murthy ,
James H.
Wilson ,
Thomas J.
Lukas§,
Robert D.
Goldman , and
Laszlo
Lorand
From the Departments of Cell and Molecular Biology
and § Molecular Pharmacology and Biological Chemistry,
Northwestern University Medical School, Chicago, Illinois 60611
Mere addition of Ca2+ to a lens
cortical homogenate (bovine) generates a series of products composed of
a variety of high molecular weight vimentin species. The
Ca2+-induced cross-linking of this cytoskeletal element
seems to be mediated by the intrinsic transglutaminase of lens, because
the reaction could be blocked at the monomeric state of vimentin by the
inclusion of small synthetic substrates of the enzyme dansylcadaverine or dansyl- -aminocaproyl-Gln-Gln-Ile-Val. These compounds
are known to compete against the Gln or Lys functionalities of
proteins that would participate in forming the
N ( -glutamyl)lysine
protein-to-protein cross-links. The cytosolic transglutaminase-catalyzed reactions could be reproduced with purified
bovine lens vimentin and also with recombinant human vimentin
preparations. Employing the latter system, we have titrated the
transglutaminase-reactive sites of vimentin and, by sequencing the
dansyl-tracer-labeled segments of the protein, we have shown that
residues Gln453 and Gln460 served as acceptor
functionalities and Lys97, Lys104,
Lys294, and Lys439 as electron donor
functionalities in vimentin. The transglutaminase-dependent reaction of this intermediate filament protein might influence the
shape and plasticity of the fiber cells, and the enzyme-catalyzed cross-linking of vimentin, in conjunction with other lens constituents, may contribute to the process of cataract formation.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. E. Iismaa, B. M. Mearns, L. Lorand, and R. M. Graham
Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
Physiol Rev,
July 1, 2009;
89(3):
991 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bornheim, M. Muller, U. Reuter, H. Herrmann, H. Bussow, and T. M. Magin
A dominant vimentin mutant upregulates Hsp70 and the activity of the ubiquitin-proteasome system, and causes posterior cataracts in transgenic mice
J. Cell Sci.,
November 15, 2008;
121(22):
3737 - 3746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-M. Shin, J.-H. Jeon, C.-W. Kim, S.-Y. Cho, J.-C. Kwon, H.-J. Lee, K.-H. Choi, S.-C. Park, and I.-G. Kim
Cell Type-specific Activation of Intracellular Transglutaminase 2 by Oxidative Stress or Ultraviolet Irradiation: IMPLICATIONS OF TRANSGLUTAMINASE 2 IN AGE-RELATED CATARACTOGENESIS
J. Biol. Chem.,
April 9, 2004;
279(15):
15032 - 15039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X H Wan, E H Lee, H J Koh, J Song, E K Kim, C Y Kim, J B Lee, S-Y Kim, K Yao, and J H Lee
Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-{beta} in vitro
Br. J. Ophthalmol.,
November 1, 2002;
86(11):
1293 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. BERNASSOLA, M. FEDERICI, M. CORAZZARI, A. TERRINONI, M. L. HRIBAL, V. DE LAURENZI, M. RANALLI, O. MASSA, G. SESTI, W.H. IRWIN MCLEAN, et al.
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient
FASEB J,
September 1, 2002;
16(11):
1371 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-s. Gao and E. Sztul
A Novel Interaction of the Golgi Complex with the Vimentin Intermediate Filament Cytoskeleton
J. Cell Biol.,
February 26, 2001;
152(5):
877 - 894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furutani, A. Kato, M. Notoya, M. A. Ghoneim, and S. Hirose
A Simple Assay and Histochemical Localization of Transglutaminase Activity Using a Derivative of Green Fluorescent Protein as Substrate
J. Histochem. Cytochem.,
February 1, 2001;
49(2):
247 - 258.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Sanderson, J. M. Marcantonio, and G. Duncan
A Human Lens Model of Cortical Cataract: Ca2+-Induced Protein Loss, Vimentin Cleavage and Opacification
Invest. Ophthalmol. Vis. Sci.,
July 1, 2000;
41(8):
2255 - 2261.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Raghunath, R. Cankay, U. Kubitscheck, J. D. Fauteck, R. Mayne, D. Aeschlimann, and U. Schlotzer-Schrehardt
Transglutaminase Activity in the Eye: Cross-linking in Epithelia and Connective Tissue Structures
Invest. Ophthalmol. Vis. Sci.,
November 1, 1999;
40(12):
2780 - 2787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Candi, S. Oddi, A. Terrinoni, A. Paradisi, M. Ranalli, A. Finazzi-Agro, and G. Melino
Transglutaminase 5 Cross-links Loricrin, Involucrin, and Small Proline-rich Proteins in Vitro
J. Biol. Chem.,
September 7, 2001;
276(37):
35014 - 35023.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|